All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
CAT | Product Name | Target Species | TCR Clone | Host Species | Epitope | Allele | Vector Type | Inquiry & Datasheet |
TCR-YC0469 | Mouse anti-Glycolipid T cell receptor (YC07), pCDTCR1 | YC07 | Mouse | (2S,3S,4R)-1-(4-O-allyl-α-d-Galactopyranosyloxy)-2-hexacosanoylaminooctadecane-3,4-diol | mouse CD1d | Lentiviral vector | ||
TCR-YC0470 | Mouse anti-Glycolipid T cell receptor (YC08), pCDTCR1 | YC08 | Mouse | (2S,3S,4R)-1-(4-O-Benzyl-α-d-galactopyranosyloxy)-2-hexacosanoylaminooctadecane-3,4-diol | mouse CD1d | Lentiviral vector | ||
TCR-YC0471 | Mouse anti-Glycolipid T cell receptor (YC09), pCDTCR1 | YC09 | Mouse | (2S,3S,4R)-1-(4-O-Cyclobutylmethyl-α-d-galactopyranosyloxy)-2-hexacosanoylaminooctadecane-3,4-diol | mouse CD1d | Lentiviral vector | ||
TCR-YC0472 | Mouse anti-Glycolipid T cell receptor (YC10), pCDTCR1 | YC10 | Mouse | (2S,3S,4R)-1-(4-O-Cyclopropylmethyl-α-d-galactopyranosyloxy)-2-hexacosanoylaminooctadecane-3,4-diol | mouse CD1d | Lentiviral vector | ||
TCR-YC0473 | Mouse anti-Glycolipid T cell receptor (YC11), pCDTCR1 | YC11 | Mouse | (2S,3S,4R)-1-(4-O-propyl-α-d-Galactopyranosyloxy)-2-hexacosanoylaminooctadecane-3,4-diol | mouse CD1d | Lentiviral vector | ||
TCR-YC0474 | Mouse anti-Glycolipid T cell receptor (YC12), pCDTCR1 | YC12 | Mouse | (2S,3S,4R)-1-[4-O-(2-Adamantylethyl)-α-d-galactopyranosyloxy]-2-hexacosanoylaminooctadecane-3,4-diol | mouse CD1d | Lentiviral vector | ||
TCR-YC0475 | Mouse anti-Glycolipid T cell receptor (YC13), pCDTCR1 | YC13 | Mouse | (2S,3S,4R)-1-[4-O-(3,4-Dichlorobenzyl)-α-d-galactopyranosyloxy]-2-hexacosanoylaminooctadecane-3,4-diol | mouse CD1d | Lentiviral vector | ||
TCR-YC0476 | Mouse anti-Glycolipid T cell receptor (YC14), pCDTCR1 | YC14 | Mouse | (2S,3S,4R)-1-[4-O-(3,4-Difluorobenzyl)-α-d-galactopyranosyloxy]-2-hexacosanoylaminooctadecane-3,4-diol | mouse CD1d | Lentiviral vector | ||
TCR-YC0477 | Mouse anti-Glycolipid T cell receptor (YC15), pCDTCR1 | YC15 | Mouse | (2S,3S,4R)-1-[4-O-(3-Phenylpropyl)-α-d-galactopyranosyloxy]-2-hexacosanoylaminooctadecane-3,4-diol | mouse CD1d | Lentiviral vector | ||
TCR-YC0478 | Mouse anti-Glycolipid T cell receptor (YC16), pCDTCR1 | YC16 | Mouse | (2S,3S,4R)-1-[4-O-(4-Fluorobenzyl)-α-d-galactopyranosyloxy]-2-hexacosanoylaminooctadecane-3,4-diol | mouse CD1d | Lentiviral vector | ||
TCR-YC0479 | Mouse anti-Glycolipid T cell receptor (YC17), pCDTCR1 | YC17 | Mouse | (2S,3S,4R)-1-[4-O-(4-Methylbenzyl)-α-d-galactopyranosyloxy]-2-hexacosanoylaminooctadecane-3,4-diol | mouse CD1d | Lentiviral vector | ||
TCR-YC0480 | Mouse anti-Glycolipid T cell receptor (YC18), pCDTCR1 | YC18 | Mouse | (2S,3S,4R)-1-[4-O-(4-Phenylbutyl)-α-d-galactopyranosyloxy]-2-hexacosanoylaminooctadecane-3,4-diol | mouse CD1d | Lentiviral vector | ||
TCR-YC0481 | Mouse anti-Glycolipid T cell receptor (YC19), pCDTCR1 | YC19 | Mouse | (2S,3S,4R)-1-[4-O-(4-tert-Butylbenzyl)-α-d-galactopyranosyloxy]-2-hexacosanoylaminooctadecane-3,4-diol | mouse CD1d | Lentiviral vector | ||
TCR-YC0482 | Mouse anti-Glycolipid T cell receptor (YC20), pCDTCR1 | YC20 | Mouse | (2S,3S,4R)-1-[4-O-(4-Trifluoromethylbenzyl)-α-d-galactopyranosyloxy]-2-hexacosanoylaminooctadecane-3,4-diol | mouse CD1d | Lentiviral vector | ||
TCR-YC0483 | Mouse anti-Glycolipid T cell receptor (YC21), pCDTCR1 | YC21 | Mouse | (2S,3S,4R)-1-[4-O-(5-Phenylpentyl)-α-d-galactopyranosyloxy]-2-hexacosanoylaminooctadecane-3,4-diol | mouse CD1d | Lentiviral vector | ||
TCR-YC0484 | Mouse anti-Glycolipid T cell receptor (YC22), pCDTCR1 | YC22 | Mouse | (2S,3S,4R)-1-[4-O-(6-Phenylhexyl)-α-d-galactopyranosyloxy]-2-hexacosanoylaminooctadecane-3,4-diol | mouse CD1d | Lentiviral vector | ||
TCR-YC0485 | Mouse anti-Glycolipid T cell receptor (YC23), pCDTCR1 | YC23 | Mouse | (2S,3S,4R)-1-{4-O-[3-(3,4-Dichlorophenyl)propyl]-α-d-galactopyranosyloxy}-2-hexacosanoylaminooctadecane-3,4-diol | mouse CD1d | Lentiviral vector | ||
TCR-YC0486 | Mouse anti-Glycolipid T cell receptor (YC24), pCDTCR1 | YC24 | Mouse | (2S,3S,4R)-1-{4-O-[3-(4-Chlorophenyl)propyl]-α-d-galactopyranosyloxy}-2-hexacosanoylaminooctadecane-3,4-diol | mouse CD1d | Lentiviral vector | ||
TCR-YC0487 | Mouse anti-Glycolipid T cell receptor (YC25), pCDTCR1 | YC25 | Mouse | (2S,3S,4R)-1-{4-O-[3-(4-Fluorophenyl)propyl]-α-d-galactopyranosyloxy}-2-hexacosanoylaminooctadecane-3,4-diol | mouse CD1d | Lentiviral vector | ||
TCR-YC0488 | Mouse anti-Glycolipid T cell receptor (YC26), pCDTCR1 | YC26 | Mouse | (2S,3S,4R)-1-{4-O-[3-(4-Methoxyphenyl)propyl]-α-d-galactopyranosyloxy}-2-hexacosanoylaminooctadecane-3,4-diol | mouse CD1d | Lentiviral vector |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION